News on this topic
AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb: A combination of the two pharmaceutical companies could create an entity valued at ...
qz.com/astrazeneca-bristol-myers-squibb-merger-talks-080326
AstraZeneca stock sinks on reports of merger talks with Bristol Myers ...
Pharma giants in reported merger talks: An agreement would invite government scrutiny on both sides of the pond.
axios.com/2026/08/03/pharma-merger-astrazeneca-bristol-myers-squibb
Pharma giants in reported merger talks
More articles on this subject
AstraZeneca Shares Drop, Bristol Myers Squibb’s Climb After Merger Talks Reports: A potential deal between AstraZeneca and Bristol Myers Squibb would create a ...
wsj.com/health/pharma/astrazeneca-shares-drop-after-reports-of-bristol-myers-squibb-merger-talks-2e313f5d
AstraZeneca Shares Drop, Bristol Myers Squibb’s Climb After Merger Talks ...
Similar to This
How a pharma megamerger could squelch R&D: Combining two drug giants with overlapping portfolios could put cost efficiencies ahead of innovation.
axios.com/2026/08/04/astrazeneca-bristol-myers-squibb-merger-drug-companies
How a pharma megamerger could squelch R&D
Inside the £64bn pharma deal that could cost more lives than Covid: With the NHS on its knees, the UK has struck a secretive new drugs deal ...
thebureauinvestigates.com/stories/2026-04-13/inside-the-64bn-pharma-deal-that-could-cost-more-lives-than-covid
Inside the £64bn pharma deal that could cost more lives than Covid
Donald Trump still isn’t done with Britain’s NHS: U.S. officials are quietly laying the groundwork to revisit the U.K.’s drug pricing deal before the end of the ...
politico.eu/article/donald-trump-us-uk-national-health-service-nhs-medicine-price/
Donald Trump still isn’t done with Britain’s NHS